Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
10.58
Nov 13 • 3:59 PM ET Dollar change+0.54 Percentage change(5.38%)
Aftermarket Close
10.44
Aftermarket • 7:57 PM ET Dollar change-0.14 Percentage change(-1.32%)
Index
RUT
Market Cap
579.58M
Enterprise Value
515.48M
Income
-122.54M
Sales
60.01M
Book/sh
1.42
Cash/sh
2.31
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
130
IPO
Dec 22, 2015
P/E
-
Forward P/E
-
PEG
-
P/S
9.66
P/B
7.47
P/C
4.58
P/FCF
-
EV/EBITDA
-
EV/Sales
8.59
Quick Ratio
5.60
Current Ratio
5.92
Debt/Eq
0.81
LT Debt/Eq
0.76
Option/Short
Yes / Yes
EPS (ttm)
-2.34
EPS next Y
-1.85
EPS next Q
-0.42
EPS this Y
-32.81%
EPS next Y
16.15%
EPS next 5Y
4.31%
EPS past 3/5Y
8.64% 35.96%
Sales past 3/5Y
29.09% 48.10%
EPS Y/Y TTM
-37.15%
Sales Y/Y TTM
104.83%
EPS Q/Q
-14.43%
Sales Q/Q
141.64%
Insider Own
11.93%
Insider Trans
0.21%
Inst Own
40.20%
Inst Trans
11.66%
ROA
-81.04%
ROE
-157.32%
ROIC
-89.64%
Gross Margin
58.72%
Oper. Margin
-200.99%
Profit Margin
-204.19%
SMA20
18.99%
SMA50
15.37%
SMA200
44.68%
Trades
Shs Outstand
54.78M
Shs Float
48.25M
52W High
13.98 -24.31%
52W Low
4.79 120.88%
Volatility
17.04% 10.15%
ATR (14)
0.94
RSI (14)
62.06
Beta
1.03
Rel Volume
1.47
Avg Volume
761.15K
Volume
1,120,691
Perf Week
23.17%
Perf Month
28.55%
Perf Quarter
31.76%
Perf Half Y
83.36%
Perf YTD
91.67%
Perf Year
71.20%
Perf 3Y
-4.68%
Perf 5Y
-85.43%
Perf 10Y
-76.17%
Prev Close
10.04
Price
10.58
Change %
5.38%
Consensus
Buy
Avg. Price Target
$15.08
Implied Upside
+42.5%
Analysts12incl. previous ratings
Rating Distribution3 Buy · 7 Hold · 2 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Nov 10, 2026Upgrade
RJF logoRRaymond James
Underperform → Mkt Perform
Oct 07, 2026Initiated
BCS logoBBarclays
Equal Weight$10-5.5%
Oct 21, 2025Resumed
SF logoSStifel
Hold$9-14.9%
Aug 27, 2025Initiated
BCS logoBBarclays
Overweight$1.50-85.8%
Jul 15, 2025Initiated
TD logoTTD Cowen
Buy$1.25-88.2%
Jun 02, 2025Resumed
HH.C. Wainwright
Buy$1.10-89.6%
Apr 10, 2025Initiated
MFG logoMMizuho
Outperform$2-81.1%
Jul 19, 2023Initiated
JEF logoJJefferies
Underperform$0.50-95.3%
Aug 19, 2021Initiated
HH.C. Wainwright
Buy$6-43.3%
Apr 01, 2021Downgrade
SSVB Leerink
Outperform → Mkt Perform$3-71.6%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ROEDER DOUGLAS ADirectorAug 19 '26Buy8.9813,953125,300171,191Aug 20 06:25 PM
ROEDER DOUGLAS ADirectorMay 12 '26Buy5.5622,686126,134144,635May 13 04:15 PM
ROEDER DOUGLAS ADirectorMar 13 '26Buy5.7317,500100,275119,731Mar 16 10:44 AM
Goodnow Timothy TPresident and CEOMar 13 '26Buy5.7917,22599,733651,243Mar 16 10:44 AM
Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.
PresidentDr. Timothy T. Goodnow Ph.D.
CFOMr. Frederick T. Sullivan CPA
Chief Operating OfficerDr. Mukul Jain Ph.D.
Chief Medical Officer & DirectorDr. Francine Ratner Kaufman M.D.
Chief Commercial Officer & DirectorMr. Brian B. Hansen